Co-administration of Systemic and Intralesional Zoledronic Acid in a Case of Fibrous Dysplasia: A Potentially Novel Therapy

Fibrous dysplasia (FD) is a benign bone lesion characterized by replacement of normal bone with abnormal fibrous tissue, clinically manifesting as deformities, bone pains, and pathological fractures. The standard medical management for FD includes systemic bisphosphonate therapy. The efficacy of sys...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhadada, Sanjay Kumar, Pal, Rimesh, Sood, Ashwani, Dhiman, Vandana, Saini, Uttam Chand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877477/
https://www.ncbi.nlm.nih.gov/pubmed/31803145
http://dx.doi.org/10.3389/fendo.2019.00803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877477/
https://www.ncbi.nlm.nih.gov/pubmed/31803145
http://dx.doi.org/10.3389/fendo.2019.00803

Ejemplares similares